Free for academic non-profit institutions. Other users need a Commercial license
The protein encoded by this gene is a cytokine receptor that belongs to the interleukin 1 receptor family. This protein binds interleukin alpha (IL1A), interleukin beta (IL1B), and interleukin 1 receptor, type I(IL1R1/IL1RA), and acts as a decoy receptor that inhibits the activity of its ligands. Interleukin 4 (IL4) is reported to antagonize the activity of interleukin 1 by inducing the expression and release of this cytokine. This gene and three other genes form a cytokine receptor gene cluster on chromosome 2q12. Alternative splicing results in multiple transcript variants and protein isoforms. Alternative splicing produces both membrane-bound and soluble proteins. A soluble protein is also produced by proteolytic cleavage. [provided by RefSeq, May 2012]
IL1R2 (Interleukin 1 Receptor Type 2) is a Protein Coding gene. Diseases associated with IL1R2 include Endometriosis and Aseptic Meningitis. Among its related pathways are IL-1 signaling pathway and MAPK signaling pathway. Gene Ontology (GO) annotations related to this gene include interleukin-1 receptor activity and interleukin-1, type II, blocking receptor activity. An important paralog of this gene is IL1RAPL2.
Cytokines are proteinaceous signaling compounds that are major mediators of the immune response. They control many different cellular functions including proliferation, differentiation and cell survival/apoptosis but are also involved in several pathophysiological processes.
GeneHancer (GH) Identifier | GH Type | GH Score |
GH Sources | Gene Association Score | Total Score | TSS distance (kb) | Number of Genes Away | Size (kb) | Transcription Factor Binding Sites |
Gene Targets |
---|---|---|---|---|---|---|---|---|---|---|
GH02J101998 | Promoter/Enhancer | 1.4 | EPDnew Ensembl ENCODE | 262.2 | +7.6 | 7627 | 1.9 | CEBPA ZFP64 HOMEZ FOXA2 SAP130 RXRA EBF1 RARA DMAP1 THRB | IL1R2 SNORD89 HSALNG0017394 IL1R1 | |
GH02J101991 | Promoter | 1.1 | EPDnew Ensembl | 250.7 | +0.3 | 296 | 0.6 | TRIM22 SPI1 CTCF ZNF48 IKZF1 HDAC2 POLR2A ZNF202 ZBTB33 IKZF2 | IL1R2 HSALNG0017394 IL1R1 | |
GH02J101992 | Promoter | 0.6 | Ensembl | 250.7 | +0.9 | 896 | 0.2 | ZNF48 HDAC2 POLR2A | IL1R2 HSALNG0017394 IL1R1 | |
GH02J101983 | Promoter | 0.6 | EPDnew | 250.4 | -8.1 | -8060 | 0.1 | CUX1 FOS EP300 | IL1R2 LINC01127 MAP4K4 | |
GH02J102008 | Promoter | 0.4 | EPDnew | 250.4 | +16.7 | 16719 | 0.1 | L3MBTL2 | HSALNG0017395 IL1R2 IL1R1-AS1 HSALNG0017394 IL1R1 |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0004908 | interleukin-1 receptor activity | IBA | 21873635 |
GO:0004910 | interleukin-1, type II, blocking receptor activity | IEA | -- |
GO:0005515 | protein binding | IPI | 1830582 |
GO:0019966 | interleukin-1 binding | IBA | 21873635 |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005576 | extracellular region | IEA | -- |
GO:0005737 | cytoplasm | IEA | -- |
GO:0005886 | plasma membrane | TAS | -- |
GO:0016020 | membrane | IEA | -- |
GO:0016021 | integral component of membrane | IEA | -- |
SuperPathway | Contained pathways | ||
---|---|---|---|
1 | MAPK Pathway |
.36
|
|
2 | IL-2 Pathway |
TREM1 Pathway
.43
|
HMGB1 Pathway
.36
|
3 | NF-KappaB Family Pathway |
NF-KappaB (p50-p65) Pathway
.72
|
NF-KappaB Family Pathway
.72
|
4 | Cytokine Signaling in Immune system | ||
5 | IL-1 signaling pathway |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0006955 | immune response | TAS | 8898719 |
GO:0010955 | negative regulation of protein processing | IEA | -- |
GO:0019221 | cytokine-mediated signaling pathway | TAS | -- |
GO:0032690 | negative regulation of interleukin-1 alpha production | IEA | -- |
GO:0070498 | interleukin-1-mediated signaling pathway | TAS | -- |
Name | Status | Disease Links | Group | Role | Mechanism of Action | Clinical Trials |
---|---|---|---|---|---|---|
Anakinra | Approved | Pharma | antagonist | IL-1 receptor antagonist | 0 | |
AF 12198 | Pharma | Type I IL-1 receptor antagonist, Potent, selective human type I IL-1 receptor antagonist | 0 | |||
Ro 26-4550 trifluoroacetate | Pharma | reversible inhibitor of interleukin-2 (IL-2) binding to its receptor, Competitive inhibitor of IL-2/ IL-2Ralpha receptor interaction | 0 | |||
YM 90709 | Pharma | Interleukin-5 receptor antagonist | 0 | |||
IL-1 | Pharma | 0 |
Name | Synonyms | Role | CAS Number | PubChem IDs | PubMed IDs | |
---|---|---|---|---|---|---|
Lyn peptide inhibitor |
|
222018-18-0 |
|
|
||
R 7050 |
|
303997-35-5 |
|
|
Compound | Action | Cas Number |
---|---|---|
AF 12198 | Potent, selective human type I IL-1 receptor antagonist | 185413-30-3 |
Lyn peptide inhibitor | Inhibits Lyn-dependent activities of IL-5 receptor; cell-permeable | 222018-18-0 |
R 7050 | Inhibitor of TNF-alpha receptor 1 signaling | 303997-35-5 |
Ro 26-4550 trifluoroacetate | Competitive inhibitor of IL-2/ IL-2Ralpha receptor interaction | 1217448-66-2 |
YM 90709 | Interleukin-5 receptor antagonist | 163769-88-8 |
Compound | Action | Cas Number |
---|---|---|
AF 12198 | Type I IL-1 receptor antagonist | 185413-30-3 |
Ro 26-4550 trifluoroacetate | reversible inhibitor of interleukin-2 (IL-2) binding to its receptor | 1217448-66-2 |
YM 90709 | 163769-88-8 |
ExUns: | 1a | · | 1b | · | 1c | · | 1d | ^ | 2a | · | 2b | ^ | 3 | ^ | 4a | · | 4b | ^ | 5a | · | 5b | · | 5c | ^ | 6 | ^ | 7a | · | 7b | · | 7c | ^ | 8 | ^ | 9a | · | 9b | ^ | 10 | ^ | 11 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SP1: | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||
SP2: | - | ||||||||||||||||||||||||||||||||||||||||
SP3: | - | - | |||||||||||||||||||||||||||||||||||||||
SP4: | - | ||||||||||||||||||||||||||||||||||||||||
SP5: | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||
SP6: | - | - | - | - | |||||||||||||||||||||||||||||||||||||
SP7: | - | - | - | ||||||||||||||||||||||||||||||||||||||
SP8: | - | - | - |
This gene was present in the common ancestor of chordates.
Organism | Taxonomy | Gene | Similarity | Type | Details |
---|---|---|---|---|---|
Chimpanzee (Pan troglodytes) |
Mammalia | IL1R2 30 31 |
|
OneToOne | |
Dog (Canis familiaris) |
Mammalia | IL1R2 30 31 |
|
OneToOne | |
Cow (Bos Taurus) |
Mammalia | IL1R2 30 31 |
|
OneToOne | |
Rat (Rattus norvegicus) |
Mammalia | Il1r2 30 |
|
||
Mouse (Mus musculus) |
Mammalia | Il1r2 30 17 31 |
|
OneToOne | |
Platypus (Ornithorhynchus anatinus) |
Mammalia | IL1R2 31 |
|
OneToOne | |
Oppossum (Monodelphis domestica) |
Mammalia | IL1R2 31 |
|
OneToOne | |
Chicken (Gallus gallus) |
Aves | IL1R2 30 31 |
|
OneToOne | |
Lizard (Anolis carolinensis) |
Reptilia | IL1R2 31 |
|
OneToOne | |
Tropical Clawed Frog (Silurana tropicalis) |
Amphibia | il1r2 30 |
|
SNP ID | Clinical significance and condition | Chr 02 pos | Variation | AA Info | Type |
---|---|---|---|---|---|
rs143906708 | Benign: not provided | 102,009,746(+) |
A/G NM_004633.4(IL1R2):c.252A>G (p.Thr84=) |
NON_CODING_TRANSCRIPT_VARIANT,SYNONYMOUS | |
rs28362312 | Likely Benign: not provided | 102,009,680(+) |
C/G NM_004633.4(IL1R2):c.186C>G (p.Ser62Arg) |
MISSENSE_VARIANT,NON_CODING_TRANSCRIPT | |
rs28385682 | Benign: not provided. - | 102,019,665(+) |
G/Ap.Glu181Lys NM_004633.4(IL1R2):c.541G>A (p.Glu181Lys) |
MISSENSE_VARIANT,NON_CODING_TRANSCRIPT | |
rs3218961 | Benign: not provided | 102,022,183(+) |
T/G NM_004633.4(IL1R2):c.689-4T>G |
INTRON | |
rs3218976 | - |
p.Glu292Lys |
Variant ID | Type | Subtype | PubMed ID |
---|---|---|---|
dgv6980n54 | CNV | loss | 21841781 |
esv2657953 | CNV | deletion | 23128226 |
esv2720456 | CNV | deletion | 23290073 |
esv2720457 | CNV | deletion | 23290073 |
esv2720458 | CNV | deletion | 23290073 |
esv2720459 | CNV | deletion | 23290073 |
esv3353381 | CNV | duplication | 20981092 |
esv3426758 | CNV | duplication | 20981092 |
nsv1132501 | CNV | duplication | 24896259 |
nsv1146528 | CNV | insertion | 26484159 |
nsv582551 | CNV | loss | 21841781 |
nsv582552 | CNV | loss | 21841781 |
Disorder | Aliases | PubMed IDs |
---|---|---|
endometriosis |
|
|
aseptic meningitis |
|
|
mastitis |
|
|